KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Gross Margin (2016 - 2025)

Historic Gross Margin for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to 65.84%.

  • Medtronic's Gross Margin rose 9000.0% to 65.84% in Q4 2025 from the same period last year, while for Oct 2025 it was 65.51%, marking a year-over-year increase of 4600.0%. This contributed to the annual value of 65.32% for FY2025, which is 300.0% down from last year.
  • Latest data reveals that Medtronic reported Gross Margin of 65.84% as of Q4 2025, which was up 9000.0% from 65.02% recorded in Q3 2025.
  • In the past 5 years, Medtronic's Gross Margin ranged from a high of 68.32% in Q1 2022 and a low of 64.56% during Q2 2024
  • In the last 5 years, Medtronic's Gross Margin had a median value of 65.85% in 2022 and averaged 66.11%.
  • In the last 5 years, Medtronic's Gross Margin surged by 59700bps in 2021 and then tumbled by -31200bps in 2023.
  • Medtronic's Gross Margin (Quarter) stood at 68.18% in 2021, then fell by -2bps to 66.58% in 2022, then dropped by -2bps to 65.42% in 2023, then dropped by -1bps to 64.94% in 2024, then increased by 1bps to 65.84% in 2025.
  • Its Gross Margin stands at 65.84% for Q4 2025, versus 65.02% for Q3 2025 and 64.75% for Q2 2025.